GT-02287

N/A

Report date: 2025/12/16 20:00:07
NME

Base Information

Drug NameGT-02287
Drug Alias NameGT-02287
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-glucocerebrosidase modulators
TargetsBeta-glucocerebrosidase
Therapy Area/IndicationsAlzheimer DiseaseGaucher DiseaseParkinson Disease +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGain Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesGain Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseGaucher DiseaseParkinson Disease +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A